Delineation of the androgen-regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 41, 1-11
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01CA184208)
- American Cancer Society (RSG-16-084-01)
This publication has 95 references indexed in Scilit:
- N-Linked Glycosylation Supports Cross-Talk between Receptor Tyrosine Kinases and Androgen ReceptorPLOS ONE, 2013
- Polyamines and cancer: implications for chemotherapy and chemopreventionExpert Reviews in Molecular Medicine, 2013
- PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signalingBMC Cancer, 2012
- The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesisThe EMBO Journal, 2011
- CaM Kinase Kinase β-Mediated Activation of the Growth Regulatory Kinase AMPK Is Required for Androgen-Dependent Migration of Prostate Cancer CellsCancer Research, 2011
- Mechanisms of Resistance to Anti-Angiogenic Therapy and Development of Third-Generation Anti-Angiogenic Drug CandidatesGenes & Cancer, 2010
- miR-21: An Androgen Receptor–Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer GrowthCancer Research, 2009
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate CancerCell, 2009
- AR, the cell cycle, and prostate cancerNuclear Receptor Signaling, 2008
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005